SEP 11, 2022 12:10 PM PDT

Effects of Ketamine in Mice Depend on Sex of Human Experimenter

WRITTEN BY: Annie Lennon

Researchers found that mice more consistently experience antidepressant effects from ketamine when administered by men and not women. The corresponding study was published in Nature Neuroscience

Those who work with mice often report that their behavior depends on who is handling them. Anecdotal reports and some scientific reports even suggest that while mice tend to be more uptight or fearful around men, they are more comfortable and relaxed around women. Whether this affects experimental results, however, is unknown. 

The current study was inspired by anecdotal evidence of ketamine consistently producing antidepressant effects when administered by male and not female researchers. To understand why this may be the case, the researchers began by observing mice's preference for t-shirts, and cotton swabs rubbed on the wrists, elbows, or behind the ears of women compared to men. 

To understand the mechanisms behind the preference, the researchers used a chemical block to disable their sense of smell. With this in place, they noted that mice no longer preferred women's cotton swabs or T-shirts over men's. This, they noted, may be as mice have a more keenly developed sense of smell than humans and, therefore, a higher sensitivity to pheromones. 

From further experiments, the researchers found that the smell of men, and not women, activated corticotropin-releasing factor (CRF) neurons in the hippocampus, which are responsible for learning and memory and have previously been linked to depression. 

To see if activation of these neurons could explain the difference in treatment outcomes among mice treated by men or women, the researchers had women administer ketamine alongside CRF to mice. In doing so, they found that mice who received ketamine alongside CRF experienced antidepressant effects, almost as if men treated them. 

"We think that some people may have higher or lower levels of CRF, and we believe that people [who] do not respond well to ketamine antidepressant therapy might respond if we could administer the treatment with some CRF-related chemical that could induce ketamine's effects," said Polymnia Georgiou, Ph.D., a former postdoctoral fellow in Dr. Gould's laboratory, who led the project.

"Alternatively, we typically see the antidepressant effects of ketamine lasting 1-3 days, but with CRF administration, it is possible that we may be able to extend the effects to last longer with CRF," she added. 

The researchers concluded that a better understanding of how the sex of human experimenters affects treatment outcomes among rodents could improve replicability between studies. They noted that it could also reveal biological and pharmacological mechanisms that could be used to improve treatment outcomes. 


Sources: Neuroscience News, Nature Neuroscience.

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
SEP 27, 2022
Clinical & Molecular DX
New Research Elucidates the Mechanism of Skin Cancer Metastasis to the Brain and Points to Groundbreaking Treatment
SEP 27, 2022
New Research Elucidates the Mechanism of Skin Cancer Metastasis to the Brain and Points to Groundbreaking Treatment
In advanced stages of skin cancer, patients develop brain metastases about 90% of the time. Though this is one of the mo ...
OCT 03, 2022
Plants & Animals
Yeast Proteins Could Provide Clues for New Antifungal Development
OCT 03, 2022
Yeast Proteins Could Provide Clues for New Antifungal Development
Yeast, like bacteria, causes infections. In fact, yeasts are responsible for over 100 million infections every year. The ...
OCT 14, 2022
Neuroscience
Being Prescribed Multiple Medications Linked to Dementia
OCT 14, 2022
Being Prescribed Multiple Medications Linked to Dementia
Within five years of being diagnosed with dementia, people are commonly prescribed three drugs or more to treat multiple ...
OCT 19, 2022
Health & Medicine
Study Reveals Retained Dust in Lungs of Military Personnel
OCT 19, 2022
Study Reveals Retained Dust in Lungs of Military Personnel
Researchers from the U.S. Geological Survey (USGS) and National Jewish Health teamed up to investigate lung disease seen ...
NOV 17, 2022
Drug Discovery & Development
Implantable Pump Delivers Chemotherapy Directly to the Brain
NOV 17, 2022
Implantable Pump Delivers Chemotherapy Directly to the Brain
An implantable pump can bypass the blood-brain barrier and deliver chemotherapy to specific brain areas. The correspondi ...
NOV 28, 2022
Neuroscience
Experimental Drug Halts Deadly Brain Cancer Growth Without Harming Brain Cells
NOV 28, 2022
Experimental Drug Halts Deadly Brain Cancer Growth Without Harming Brain Cells
  Researchers have found that blocking a certain enzyme halts the growth of a childhood brain cancer tumor. The cor ...
Loading Comments...